Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infliximab versus Cyclophosphamide for Severe Behçet's Syndrome.
Saadoun D, Maalouf G, Vieira M, Trad S, Lazaro E, Sacre K, Plessier A, Sené T, Koné-Paut I, Noel N, Mekinian A, Lambert M, Ribeiro E, Mirault T, Mele N, Dellal A, Fain O, Melki I, Chiche L, Gaudric J, Redheuil A, Maillart E, Ghembaza A, Desbois AC, Mirouse A, Domont F, Leroux G, Ferfar Y, Rigolet A, Viallard JF, Vautier M, Resche-Rigon M, Cacoub P. Saadoun D, et al. Among authors: ghembaza a. NEJM Evid. 2024 Nov;3(11):EVIDoa2300354. doi: 10.1056/EVIDoa2300354. Epub 2024 Oct 22. NEJM Evid. 2024. PMID: 39437137 Clinical Trial.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Behçet's disease uveitis.
Joubert M, Desbois AC, Domont F, Ghembaza A, Lejoncour A, Mirouse A, Maalouf G, Leclercq M, Touhami S, Cacoub P, Bodaghi B, Saadoun D. Joubert M, et al. Among authors: ghembaza a. Rev Med Interne. 2023 Oct;44(10):546-554. doi: 10.1016/j.revmed.2023.06.004. Epub 2023 Jul 4. Rev Med Interne. 2023. PMID: 37414674 Review.
Behçet's Disease Uveitis.
Joubert M, Desbois AC, Domont F, Ghembaza A, Le Joncour A, Mirouse A, Maalouf G, Leclercq M, Touhami S, Cacoub P, Bodaghi B, Saadoun D. Joubert M, et al. Among authors: ghembaza a. J Clin Med. 2023 May 24;12(11):3648. doi: 10.3390/jcm12113648. J Clin Med. 2023. PMID: 37297843 Free PMC article. Review.
Prognosis and long-term outcomes in type I cryoglobulinemia: A multicenter study of 168 patients.
Ghembaza A, Boleto G, Bommelaer M, Karras A, Javaugue V, Bridoux F, Alyanakian MA, Molinier Frenkel V, Ghillani-Dalbin P, Musset L, Barete S, Roosweil D, Choquet S, Le Joncour A, Mirouse A, Lipsker D, Faguer S, Vieira M, Cacoub P, Biard L, Saadoun D; from the French Cryoglobulinemia Network. Ghembaza A, et al. Am J Hematol. 2023 Jul;98(7):1080-1086. doi: 10.1002/ajh.26944. Epub 2023 May 4. Am J Hematol. 2023. PMID: 37139676 Free article.
[Thoracic manifestations of Behcet's disease].
Ghembaza A, Boussouar S, Saadoun D. Ghembaza A, et al. Rev Mal Respir. 2022 Jun;39(6):523-533. doi: 10.1016/j.rmr.2022.04.010. Epub 2022 May 31. Rev Mal Respir. 2022. PMID: 35659162 Review. French.
Perspectives for immunotherapy in noninfectious immune mediated uveitis.
Touhami S, Gueudry J, Leclercq M, Touitou V, Ghembaza A, Errera MH, Saadoun D, Bodaghi B. Touhami S, et al. Among authors: ghembaza a. Expert Rev Clin Immunol. 2021 Sep;17(9):977-989. doi: 10.1080/1744666X.2021.1956313. Epub 2021 Jul 26. Expert Rev Clin Immunol. 2021. PMID: 34264142 Review.
Response.
Ghembaza A, Pourcher V, Saadoun D. Ghembaza A, et al. Chest. 2020 Dec;158(6):2705-2706. doi: 10.1016/j.chest.2020.07.011. Chest. 2020. PMID: 33280760 No abstract available.
14 results